Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Vetter has been named Best Managed Company in its anniversary year for the sixth time in a row. The award demonstrates how Vetter pursues its strategic goals in a focused and action-driven manner. The jury recognizes the company’s long-term thinking ...
read more
Waters Corporation has acquired Halo Labs™, a provider of specialized imaging technologies to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies.
read more
Ingenza announced its relocation to The Moubray Building at Edinburgh Technopole, part of the Pioneer Group. The new site is still within the Midlothian Science Zone – a world-leading center of research excellence in life sciences – and is now fully ...
read more
Shilpa Biologicals announced the opening of a dedicated bioconjugation suite at its Dharwad site [India]. Located adjacent to the company’s existing commercial biologics manufacturing facility, the suite is currently undergoing validation and is ...
read more
Lonza announced the launch of its new Design2Optimize™ platform to enhance process development and manufacturing of small molecule APIs.
read more
SISCAPA Assay Technologies, a provider of high-sensitivity protein quantitation, and Biognosys, a provider of next-generation proteomics, announced an exclusive strategic collaboration to offer biopharma customers a streamlined end-to-end solution ...
read more
ITM Isotope Technologies Munich SE (ITM), a radiopharmaceutical biotech company, and Radiopharm Theranostics , a developer of radiopharmaceutical products for both diagnostic and therapeutic uses, announced the signing of a supply agreement that ...
read more
PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, announced the signing of a Letter of Intent (LOI) with the Korean biotech company DewCell ...
read more
Oligo Factory, a provider of high-quality custom DNA and RNA oligonucleotides for therapeutic, diagnostic, and life science applications, announced the launch of its new low-scale oligo synthesis capability. This expansion enhances the company’s ...
read more
PeptiSystems has formed an exclusive global partnership with Asahi Kasei Bioprocess America (AKBA. The collaboration combines PeptiSystems' flow-through instrument platform with AKBA's high-performance column technology - giving customers a ...
read more
Orphan Therapeutics Accelerator, a non-profit biotech dedicated to advancing therapies for ultra-rare conditions, announced that Viralgen has become a Contract Development and Manufacturing Organization partner within OTXL's Orphan ClinDevNet network...
read more
QuVa Pharma has added another forward distribution center to its existing 503B sterile injectable compounded medications platform. Quva now has two dedicated forward distribution facilities, with the new 20,000 sq. ft. distribution facility in Sugar ...
read more
Silo Pharma has engaged Veloxity Labs for bioanalysis supporting the ongoing investigational new drug (IND)-enabling GLP (Good Laboratory Practice)-compliant toxicology and toxicokinetics study of its lead asset, SPC-15, an intranasal prophylactic ...
read more
Vetter announced that Managing Director Peter Soelkner will step down from his role at his request. He has decided to pursue new challenges outside of the company.
read more
Andelyn Biosciences has manufactured a viral vector with its AAV Curator® Platform for the Nationwide Children’s Hospital’s Cellular Therapy and Cancer Immunology Program. The Adeno-Associated Virus (AAV) will be utilized in a novel cell therapy for ...
read more